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Despite more than 25 years of investigation, the physiologic 
and clinical significance of the systolic pressure gradient 
measured across the left ventricular outflow tract in many 
patients with hypertrophic cardiomyopathy remains a sub- 
ject of controversy and seemingly endless debate. This 
controversy appears destined to continue into the foresee- 
able future. Several aspects of the complex interplay be- 
tween left ventricular morphologic and functional abnormal- 
ities during systolic ejection in hypertrophic cardiomyopathy 
have been scrutinized and debated. These include the high 
velocity of blood ejected in early systole by the hyperdy- 
namic left ventricle, the anatomic narrowing of the outflow 
tract and the importance of systolic anterior motion of the 
mitral valve leaflets in the genesis of the gradient. At the core 
of this debate, however, are the timing and completeness of 
left ventricular ejection; whether the left ventricle ejects 
against a true impediment to emptying (l-3), with forward 
flow continuing for the duration of systole (and for the 
duration of the pressure gradient), or whether the pressure 
gradient arises from cavity obliteration after the supereject- 
ing left ventricle has emptied its contents very rapidly in 
early systole, with continued isovolumic contraction during 
the remainder of systole (4-7). 
Relation between the pressure gradient and ejection time. 
The findings of Sasson et al. (8) reported in this issue of the 
Journal provide additional compelling data in support of the 
concept that the pressure gradient in hypertrophic cardio- 
myopathy represents a true obstruction to left ventricular 
ejection. These investigators demonstrated highly significant 
correlations between the magnitude of the pressure gradient 
and prolongation of left ventricular ejection time under 
conditions at rest and during drug interventions to raise or 
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lower the gradient, and also between changes in the pressure 
gradient and changes in the ejection time during these 
pharmacologic maneuvers. These particular findings them- 
selves are not new or unique, in that earlier data from the 
same group of investigators provided similar information 
nearly 22 years ago. In the previous study, however, Wigle 
et al. (9) did not hold heart rate constant during the various 
drug interventions, and the influence of heart rate on ejection 
time had to be corrected mathematically, a potential weak- 
ness and source of criticism. The current data (8), obtained 
at a heart rate held constant by atria1 pacing, are helpful in 
confirming the earlier observations regarding the significant 
quantitative relation between the pressure gradient and the 
duration of systolic ejection: the greater the gradient the 
more prolonged the ejection time. Prolongation of ejection 
time is strong evidence that the pressure gradient is indeed 
obstructive. 
Outflow obstruction versus cavity obliteration. On the 
other hand, the data of Sasson et al. (8) are not completely 
incompatible with the concept proposed by Criley and Siegel 
(7) that the pressure gradient arises from cavity obliteration 
after termination of left ventricular ejection in mid-systole. 
In this model, the ejection time as measured from aortic flow 
signals will be short but the systolic ejection period as 
estimated from the aortic dicrotic notch may be prolonged, 
stemming from impaired left ventricular relaxation with 
delay in the pressure decline required to develop a negative 
gradient and to generate retrograde aortic flow (7). Thus, a 
delayed dicrotic notch may not be proof of outflow obstruc- 
tion. As Sasson et al. (8) measured the ejection time as the 
interval from the onset of the left ventricular pressure 
upstroke to the trough of the dicrotic notch without simul- 
taneous flow measurements, one might argue that the pro- 
longed ejection times in association with high pressure 
gradients in their study could reflect a greater degree of 
cavity obliteration during inotropic stimulation, with a more 
prolonged late systolic isovolumic contraction phase before 
the onset of ventricular relaxation and aortic valve closure. 
However, the isoproterenol data of Sasson et al. (8) argue 
against this possibility. Beta-adrenergic stimulation with 
isoproterenol increases the rate and extent of left ventricular 
relaxation in hypertrophic cardiomyopathy, on the basis 
either of direct effects on myocardial inactivation or of 
loading effects related to increased systolic shortening (IO). 
If the prolonged ejection period in hypertrophic cardiomy- 
opathy arises from impaired relaxation, isoproterenol would 
have been expected to cause a decrease in ejection time 
rather than the observed increase. 
There are additional data to support the conclusion of 
Sasson and coworkers (8) that the pressure gradient in 
hypertrophic cardiomyopathy is associated with true imped- 
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iment to left ventricular outflow. Although some studies. 
using either contrast ventriculography (5) or electromagnetic 
flow velocity catheters in the ascending aorta (61, have 
suggested that systolic ejection in patients with an outflow 
gradient is brief and terminates prematurely in mid-systole, 
an early study (11) using intraoperative electromagnetic flow 
probes on the ascending aorta. as well as more recent data 
(12-19) obtained using Doppler echocardiography. contrast 
ventriculography, and radionuclide angiography have dem- 
onstrated that the left ventricular ejection time is prolonged 
in hypertrophic cardiomyopathy, as determined by contin- 
ued and prolonged ejection of ventricular stroke volume 
throughout the duration of the gradient to the end of systole. 
Even the aortic flow signals of Murgo et al. (61, reported as 
evidence that ejection is completed much earlier in systole in 
hypertrophic cardiomyopathy than in the normal heart, can 
be interpreted to demonstrate continued aortic flow through 
late systole and throughout the duration of the pressure 
gradient (20). Moreover, echocardiographic data (13) in pa- 
tients with an outflow gradient indicate that the left ventricle 
continues to shorten during the latter stages of systole. 
evidence that it is not contracting isovolumically. Cavity 
obliteration is not a consistent finding in patients with 
outflow tract gradients and, when present, usually occurs as 
a late systolic event after the pressure gradient is well es- 
tablished (17). 
Clinical implications. The interpretation of the outflow 
gradient as representing an obstruction to left ventricular 
ejection, rather than as an incidental finding with no clinical 
significance. has practical relevance in the management of 
patients with hypertrophic cardiomyopathy. especially those 
patients whose symptoms prove refractory to standard med- 
ical therapy. In the majority of such patients. operative relief 
of the outflow gradient is associated with lessening of 
symptoms and improved exercise tolerance (I ,3,21.22). 
Independent of the obstructive aspects of the pressure 
gradient. patients with an outflow gradient and high peak left 
ventricular systolic pressure are also faced with excessive 
myocardial oxygen demands. Such patients manifest hemo- 
dynamic and metabolic evidence of more severe myocardial 
ischemia during pacing-induced tachycardia than in patients 
without obstruction (23). These abnormalities markedly di- 
minish, and in many patients normalize, after operation (24). 
The preceding discussion focusing on the obstructive 
pressure gradient must be placed in perspective with the 
other clinically relevant features of hypertrophic cardiomy- 
opathy, including myocardial ischemia potentiated by re- 
duced small vessel vasodilator reserve, impaired left ventric- 
ular diastolic function and atrial and ventricular arrhythmias. 
Hypertrophic cardiomyopathy is a heterogeneous. multifac- 
eted disease. and in individual patients, these additional 
pathophysiologic features. with or without a pressure gradi- 
ent, may contribute importantly to their clinical presenta- 
tion. In other patients. however. outflow tract obstruction is 
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a major determinant of symptoms and reduced effort toler- 
ance, and the recognition and treatment of outflow obstruc- 
tion have important clinical implications. 
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